Frankfurt
21.11.24
08:10 Uhr
0,125 Euro
+0,007
+5,93 %
+5,93 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Vext Science reports Q3 results | 2 | Seeking Alpha | ||
| Do | VEXT Science, Inc.: Vext Reports Solid Financial Results for Q3 2024 | 405 | Newsfile | Generated $9.0 million in revenue and Adjusted EBITDA1 of $2.9 million, driven by early growth from rollout of adult-use sales in Ohio, market share gains in Arizona and disciplined cost control.Well... ► Artikel lesen | |
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 07.11. | Vext Science Inc: Vext Science to release Q3 2024 results Nov. 21 | 4 | Stockwatch | ||
| 07.11. | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2024 on November 21, 2024 | 224 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
| 23.09. | Vext Science Inc: Vext Science hires PartnerCap for IR services | 2 | Stockwatch | ||
| 23.09. | VEXT Science, Inc.: Vext Engages PartnerCap Securities, LLC | 533 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 23, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 21.08. | Vext Science Inc: Vext Science omits Q2 net P&L in NR, talks revenue | 2 | Stockwatch | ||
| 20.08. | Vext Science reports Q2 results | 2 | Seeking Alpha | ||
| 20.08. | VEXT Science, Inc.: Vext Announces Financial Results for Q2 2024 | 353 | Newsfile | Revenue of $8.4 million; Adjusted EBITDA1 of $1.1 million.With one of the largest footprints in Ohio amongst publicly traded peers, Vext is well-positioned to grow revenue and cash flow from operations... ► Artikel lesen | |
| 09.08. | Vext Science Inc: Vext Science to release Q2 2024 results Aug. 20 | 2 | Stockwatch | ||
| 09.08. | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2024 on August 20, 2024 | 657 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 9, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
| 02.08. | Vext Science Inc: Vext Science receives Ohio okay for adult use cannabis | 1 | Stockwatch | ||
| 02.08. | VEXT Science, Inc.: Vext to Commence Adult-Use Cannabis Sales in Ohio on August 6 | 802 | Newsfile | The Company has an operating Tier I cultivation facility, manufacturing facility and two strategically located retail dispensaries in Jackson and Columbus with two more dispensaries in the pipeline1.... ► Artikel lesen | |
| 17.07. | VEXT Science, Inc.: Vext Secures Dual-Use Provisional Licenses, Nears Launch of Adult-Use Cannabis Sales in Ohio | 231 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 16, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 25.06. | Vext Science Inc: Vext claims former auditor not professional, competent | 2 | Stockwatch | ||
| 29.05. | Earnings call: Vext Science navigates market pressure with robust Ohio growth | 2 | Investing.com | ||
| 29.05. | Vext Science Inc: Vext Science loses $6.33-million (U.S.) in Q1 2024 | 1 | Stockwatch | ||
| 29.05. | Vext Science reports Q1 results | 2 | Seeking Alpha | ||
| 29.05. | VEXT Science, Inc.: Vext Announces Financial Results for Q1 2024 | 355 | Newsfile | Revenue of $8.4 million; Adjusted EBITDA1 of $1.9 million.With launch of adult-use program in Ohio anticipated to occur in the near term, Vext will benefit from its vertically-integrated position in... ► Artikel lesen | |
| 24.05. | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2024 on May 29, 2024 | 291 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 24, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,090 | +0,05 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
| CANOPY GROWTH | 3,635 | -0,68 % | What's Happening With Canopy Growth: Is It Time To Buy? | ||
| TILRAY BRANDS | 1,249 | -0,48 % | Tilray Brands Inc: Tilray, Montlake team release game-day gold lager | ||
| INNOCAN PHARMA | 0,152 | -2,57 % | Breaking News: InnoCan Pharma erzielt 24 Mio. USD Umsatz… | ||
| TAAT GLOBAL ALTERNATIVES | 0,111 | 0,00 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CRONOS GROUP | 1,940 | +0,31 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| SYNBIOTIC | 5,320 | -2,92 % | EQS-News: SYNBIOTIC SE: In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Sonstiges
In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC
14.11.2024 / 13:30 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| TRANSCANNA | 0,017 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| ORGANIGRAM | 1,454 | +1,25 % | Organigram Reports Third Quarter Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter... ► Artikel lesen | |
| CRESCO LABS | 1,125 | +2,27 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 8,885 | +0,45 % | Grünes Gold!: Gesundheit so wichtig wie nie! Medizinische Revolution durch diese Aktie! | ||
| SNDL | 1,909 | +0,26 % | SNDL Appoints New Chief Information Officer and New President, Liquor Division | ||
| MYDECINE INNOVATIONS GROUP | 0,003 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen |
Das Unternehmen VEXT SCIENCE INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,125 Euro und damit +5,93 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.
